Vaxart (OTC:VXRT) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $(0.05) by 580 percent. This is a 700 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $104.239 million which beat the analyst consensus estimate of $69.700 million by 49.55 percent. This is a 586.46 percent increase over sales of $15.185 million the same period last year.